Hui Guo

Concurrent inhibition of pBADS99 synergistically improves MEK inhibitor efficacy in KRASG12D-mutant pancreatic ductal adenocarcinoma

P. Lobie, Y. Tan, Xi Zhang, 2024, Cell death & disease.

Vertical pathway inhibition of receptor tyrosine kinases and BAD with synergistic efficacy in triple negative breast cancer

P. Lobie, Dukanya Dukanya, Y. Tan, 2024, NPJ precision oncology.